EP08.01-110 Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in Mnsclc
Journal of Thoracic Oncology（2022）
关键词
T Cell Therapy,Cancer Immunotherapy,Tumor Microenvironment,Tumor Regression,Targeted Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要